Advertisement
GE Healthcare
GE Healthcare

Most Recent

image: Deliberating Over Danger

Deliberating Over Danger

By | April 1, 2012

The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

16 Comments

image: Finding Phenotypes

Finding Phenotypes

By | April 1, 2012

Genes shared across species that produce different phenotypes – deafness in humans and directional growth in plants – may reveal new models of disease.

14 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2012

April 2012's selection of notable quotes

2 Comments

image: Failed Drugs Expose Preclinical Blunders

Failed Drugs Expose Preclinical Blunders

By | March 30, 2012

Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.

2 Comments

image: Courts Re-Examining Gene Patents

Courts Re-Examining Gene Patents

By | March 28, 2012

The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.

2 Comments

image: More Oversight for Omics Tests

More Oversight for Omics Tests

By | March 27, 2012

A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.

0 Comments

image: Mouse Made For You

Mouse Made For You

By | March 23, 2012

Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.

4 Comments

image: My DNA, My Results

My DNA, My Results

By | March 22, 2012

Are donors of biological material privy to research results that stem from their donation?

2 Comments

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.

12 Comments

Advertisement
LI-COR
LI-COR

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  4. Four-legged Snake Fossil Found
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement